biotherapeutics

Lonza to Add Early Development Services in US

Swiss CMDO Lonza said it will expand its Early Development Services (EDS) offering into North America with a new laboratory in Cambridge, Massachusetts, set to open in May this year.

Managing Supply for Complex Biotherapeutics

Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process and access to a range of large- and small-molecule manufacturing assets.

Lonza and Chr Hansen in Biotherapeutics JV

Bridging the Innovation Gap

Roche Buys Rights to Potential Ocular Therapy

Pfizer and Calibr Collaborate on Heart Failure Drugs

GeneQuine Biotherapeutics Closes Seed Financing